Weiss Asset Management LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Theravance Biopharma, Inc. 13D/A Amendment 4
TBPH · G8807B106
0% 9/25/2026
Event 9/23/2026
RE/MAX Holdings, Inc. 13G
RMAX · 75524W108
6.8% 8/14/2026
Event 6/30/2026
Canaan Inc. 13G/A Amendment 1
CAN · 134748102
5.2% 8/11/2026
Event 6/30/2026
Semler Scientific, Inc. 13G/A Amendment 1
SMLR · 81684M104
0% 5/11/2026
Event 3/31/2026
Empery Digital Inc. 13G
EMPD · 92864V608
6.3% 5/11/2026
Event 3/31/2026
Apartment Investment & Management Co 13G
AIV · 03748R747
5.7% 5/11/2026
Event 3/31/2026
Theravance Biopharma, Inc. 13D/A Amendment 3
TBPH · G8807B106
14.5% 3/25/2026
Event 3/23/2026
New America Acquisition I Corp. 13G
NWAX · 023634108
5.4% 2/17/2026
Event 12/31/2025
Bakkt, Inc. 13G/A Amendment 1
BKKT · 05759B305
3.4% 2/17/2026
Event 12/31/2025
SITE Centers Corp. 13G/A Amendment 1
SITC · 82981J851
4.6% 2/12/2026
Event 12/31/2025
Semler Scientific, Inc. 13G
SMLR · 81684M104
5.2% 2/11/2026
Event 12/31/2025
scPharmaceuticals Inc. 13G/A Amendment 1
SCPH · 810648105
0% 2/11/2026
Event 12/31/2025
Canaan Inc. 13G
CAN · 134748102
6.6% 2/11/2026
Event 12/31/2025
SITE Centers Corp. 13G
SITC · 82981J851
5.9% 11/12/2025
Event 9/30/2025
scPharmaceuticals Inc. 13G
SCPH · 810648105
5.4% 11/12/2025
Event 9/30/2025
Bakkt Holdings, Inc. 13G
BKKT · 05759B305
5.1% 11/12/2025
Event 9/30/2025
Coincheck Group N.V. 13G/A Amendment 4
CNCK · N20967118
0.2% 2/12/2025
Event 12/31/2024
Equity Commonwealth 13G/A Amendment 1
EQC · 294628102
8.8% 1/30/2025
Event 12/31/2024